Free Trial
→ New “Trump” currency proposed in DC (From Paradigm Press) (Ad) Buy IBEX Stock  Free IBEX Stock Alerts

IBEX (IBEX) Financials

IBEX logo
$23.35 -0.11 (-0.47%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$23.34 -0.01 (-0.04%)
As of 04/17/2025 04:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for IBEX

Annual Income Statements for IBEX

This table shows IBEX's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders		 -16 11 7.77 13 21 32 34
Consolidated Net Income / (Loss)		 -16 11 7.77 13 21 32 34
Net Income / (Loss) Continuing Operations		 -21 -4.52 7.77 13 21 32 34
Total Pre-Tax Income 		-21 -0.90 10 15 19 40 41
Total Operating Income		 -18 6.44 23 17 21 40 39
Total Gross Profit		 81 110 129 443 493 523 509
Total Revenue		 342 368 405 443 493 523 509
Operating Revenue		 342 368 405 443 493 523 509
Total Cost of Revenue		 261 259 277 0.00 0.00 0.00 0.00
Total Operating Expenses		 99 103 106 426 472 483 469
Selling, General & Admin Expense		 - 28 17 77 80 89 93
Depreciation Expense		 12 21 24 14 18 19 19
Other Operating Expenses / (Income)		 86 54 64 335 374 375 357
Total Other Income / (Expense), net		 -3.09 -7.35 -13 -1.89 -1.25 -0.15 1.56
Interest Expense		 - - - 1.89 1.29 0.79 0.51
Interest & Investment Income		 - - - - 0.04 0.64 2.07
Income Tax Expense		 -0.11 3.62 2.32 2.06 -2.08 8.74 7.33
Basic Earnings per Share		 - $0.00 - $0.74 $1.18 $1.74 $1.90
Weighted Average Basic Shares Outstanding		 - - 13.05M 17.65M 18.23M 18.20M 17.70M
Diluted Earnings per Share		 - ($0.36) - $0.71 $1.15 $1.67 $1.84
Weighted Average Diluted Shares Outstanding		 - - 13.05M 18.36M 18.72M 18.89M 18.26M
Weighted Average Basic & Diluted Shares Outstanding		 - - 13.05M 18.40M 18.25M 18.30M 16.80M

Quarterly Income Statements for IBEX

This table shows IBEX's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Net Income / (Loss) Attributable to Common Shareholders		 6.52 9.27 11 4.51 7.43 6.08 10 9.85 7.53 9.27
Consolidated Net Income / (Loss)		 6.52 9.27 11 4.51 7.43 6.08 10 9.85 7.53 9.27
Net Income / (Loss) Continuing Operations		 6.52 9.27 11 4.51 7.43 6.08 10 9.85 7.53 9.27
Total Pre-Tax Income 		7.57 11 13 8.32 8.81 7.35 12 13 9.51 12
Total Operating Income		 7.67 11 13 8.31 8.33 6.95 11 13 9.09 12
Total Gross Profit		 128 139 132 124 36 37 40 307 130 141
Total Revenue		 128 139 132 124 125 133 127 125 130 141
Operating Revenue		 128 139 132 124 125 133 127 125 130 141
Total Cost of Revenue		 0.00 0.00 0.00 - 88 96 87 -183 0.00 0.00
Total Operating Expenses		 120 128 119 116 28 30 28 295 121 129
Selling, General & Admin Expense		 19 24 22 24 23 25 24 22 26 26
Depreciation Expense		 4.68 4.58 4.67 5.05 5.04 4.95 4.87 4.61 4.37 4.29
Other Operating Expenses / (Income)		 96 100 92 87 - - - - 90 99
Total Other Income / (Expense), net		 -0.10 -0.16 0.10 0.01 0.48 0.40 0.31 0.37 0.42 -0.31
Interest Expense		 0.15 0.30 0.11 0.24 0.10 0.11 0.12 0.18 0.16 0.62
Interest & Investment Income		 0.05 0.14 0.21 0.25 0.59 0.51 0.43 0.54 0.58 0.31
Income Tax Expense		 1.05 2.02 1.87 3.81 1.39 1.27 1.28 3.39 1.98 2.35
Basic Earnings per Share		 $0.36 $0.51 $0.62 $0.25 $0.41 $0.34 $0.59 $0.56 $0.45 $0.61
Weighted Average Basic Shares Outstanding		 18.14M 18.15M 18.23M 18.20M 18.29M 17.89M 17.47M 17.70M 16.88M 15.13M
Diluted Earnings per Share		 $0.35 $0.49 $0.59 $0.24 $0.39 $0.33 $0.57 $0.55 $0.43 $0.57
Weighted Average Diluted Shares Outstanding		 18.64M 18.86M 19.07M 18.89M 18.90M 18.44M 18.04M 18.26M 17.49M 16.46M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 18.30M 17.94M 17.57M 17.21M 16.80M 16.76M 13.19M

Annual Cash Flow Statements for IBEX

This table details how cash moves in and out of IBEX's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents		 -8.42 -4.24 9.64 36 -9.01 8.60 5.29
Net Cash From Operating Activities		 -5.75 2.20 52 16 40 42 36
Net Cash From Continuing Operating Activities		 -6.37 3.20 50 16 40 42 36
Net Income / (Loss) Continuing Operations		 -16 19 10 13 21 32 34
Consolidated Net Income / (Loss)		 -16 19 10 13 21 32 34
Depreciation Expense		 12 22 24 14 18 19 19
Non-Cash Adjustments To Reconcile Net Income		 7.41 5.56 0.52 18 17 20 20
Changes in Operating Assets and Liabilities, net		 -10 -44 15 -29 -16 -29 -37
Net Cash From Investing Activities		 -5.44 -9.08 -4.84 -21 -26 -19 -8.86
Net Cash From Continuing Investing Activities		 -5.44 -9.08 -4.84 -21 -26 -19 -8.86
Purchase of Property, Plant & Equipment		 -5.19 -5.61 -4.28 -21 -26 -19 -8.86
Divestitures		 - - - 0.00 0.00 -0.09 0.00
Net Cash From Financing Activities		 3.19 2.55 -34 41 -22 -14 -22
Net Cash From Continuing Financing Activities		 3.19 2.55 -34 41 -22 -14 -22
Repayment of Debt		 -218 -185 -150 -128 -106 -58 -0.29
Repurchase of Common Equity		 - 0.00 0.00 -1.07 -3.41 -0.28 -22
Issuance of Debt		 224 205 129 118 88 43 0.24
Other Financing Activities, net		 -3.16 -17 -12 -6.99 -0.78 1.61 -0.12
Effect of Exchange Rate Changes		 0.20 -0.32 -0.02 -0.18 -0.97 -0.61 -0.02
Cash Interest Paid		 - - - 1.89 1.25 0.15 0.51
Cash Income Taxes Paid		 - - - 5.67 2.16 4.28 7.69

Quarterly Cash Flow Statements for IBEX

This table details how cash moves in and out of IBEX's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Net Change in Cash & Equivalents		 -5.98 -4.77 5.59 14 4.60 -13 1.65 12 -0.42 -42
Net Cash From Operating Activities		 5.56 5.29 14 17 8.68 -1.64 11 17 7.76 1.14
Net Cash From Continuing Operating Activities		 5.56 5.29 14 17 8.68 -1.64 11 17 7.76 1.14
Net Income / (Loss) Continuing Operations		 6.52 9.27 11 4.51 7.43 6.08 10 9.85 7.53 9.27
Consolidated Net Income / (Loss)		 6.52 9.27 11 4.51 7.43 6.08 10 9.85 7.53 9.27
Depreciation Expense		 4.68 4.58 4.67 5.05 5.04 4.95 4.87 4.61 4.37 4.29
Non-Cash Adjustments To Reconcile Net Income		 4.96 5.68 4.99 4.82 4.37 5.03 5.46 4.86 4.08 4.56
Changes in Operating Assets and Liabilities, net		 -11 -14 -7.38 3.06 -8.15 -18 -9.21 -1.89 -8.22 -17
Net Cash From Investing Activities		 -3.56 -7.95 -3.81 -3.72 -2.05 -2.89 -1.69 -2.22 -3.63 -4.32
Net Cash From Continuing Investing Activities		 -3.56 -7.95 -3.81 -3.72 -2.05 -2.89 -1.69 -2.22 -3.63 -4.32
Purchase of Property, Plant & Equipment		 -3.56 -7.95 -3.73 -3.72 -2.05 -2.89 -1.69 -2.22 -3.63 -4.32
Net Cash From Financing Activities		 -7.67 -2.18 -3.91 0.13 -1.97 -8.55 -8.06 -3.15 -4.60 -39
Net Cash From Continuing Financing Activities		 -7.67 -2.18 -3.91 0.13 -1.97 -8.55 -8.06 -3.15 -4.60 -39
Repayment of Debt		 -17 -33 -8.51 -0.06 -0.09 -0.06 -0.06 -0.09 -0.06 -1.60
Repurchase of Common Equity		 -0.28 - - - -1.83 -8.44 -8.28 -3.01 -4.81 -47
Issuance of Debt		 9.36 30 4.08 0.06 0.04 0.06 0.06 0.09 0.06 9.10
Other Financing Activities, net		 -0.06 1.00 0.53 0.13 -0.08 -0.11 0.21 -0.14 0.21 0.16
Effect of Exchange Rate Changes		 -0.32 0.06 -0.26 -0.10 -0.07 0.07 -0.03 0.00 0.05 -0.02
Cash Interest Paid		 0.15 0.30 0.11 -0.40 0.10 0.11 0.12 0.18 0.16 0.62
Cash Income Taxes Paid		 0.12 1.86 0.95 1.36 1.09 2.93 1.41 2.26 3.38 3.40

Annual Balance Sheets for IBEX

This table presents IBEX's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024
Total Assets		 188 195 274 294 293 294
Total Current Assets		 82 86 141 142 159 180
Cash & Equivalents		 8.87 22 58 49 57 63
Accounts Receivable		 73 64 83 75 86 99
Prepaid Expenses		 - - - 7.14 6.62 7.71
Current Deferred & Refundable Income Taxes		 - - - 6.39 5.97 9.08
Other Current Assets		 - - - 4.56 2.19 1.89
Plant, Property, & Equipment, net		 82 85 31 42 0.00 0.00
Total Noncurrent Assets		 21 22 101 110 135 114
Goodwill		 12 12 12 12 12 12
Noncurrent Deferred & Refundable Income Taxes		 2.52 2.22 4.25 9.28 4.59 4.29
Other Noncurrent Operating Assets		 3.40 4.83 81 89 118 98
Total Liabilities & Shareholders' Equity		 188 195 274 294 293 294
Total Liabilities		 180 179 194 181 143 128
Total Current Liabilities		 111 106 106 98 73 71
Short-Term Debt		 42 27 27 15 0.41 0.66
Accounts Payable		 47 53 55 21 19 17
Current Deferred Revenue		 - - - 8.60 6.41 4.75
Current Deferred & Payable Income Tax Liabilities		 1.47 3.09 3.66 2.97 3.02 6.08
Current Employee Benefit Liabilities		 - - - 33 29 31
Other Current Liabilities		 11 22 20 16 15 12
Total Noncurrent Liabilities		 68 73 88 83 70 57
Long-Term Debt		 7.18 3.78 1.80 0.66 0.60 0.87
Noncurrent Deferred Revenue		 - - - 3.99 1.38 1.13
Other Noncurrent Operating Liabilities		 2.36 7.49 14 78 68 55
Total Equity & Noncontrolling Interests		 8.63 16 81 113 150 166
Total Preferred & Common Equity		 8.63 16 81 113 150 166
Total Common Equity		 8.63 16 81 113 150 166
Common Stock		 96 96 158 198 205 210
Retained Earnings		 -117 -110 -111 -76 -45 -11
Treasury Stock		 - - - -3.41 -3.68 -25
Accumulated Other Comprehensive Income / (Loss)		 - - - -4.56 -6.31 -7.91

Quarterly Balance Sheets for IBEX

This table presents IBEX's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025
Total Assets		 295 298 290 306 272
Total Current Assets		 168 169 171 189 159
Cash & Equivalents		 62 49 51 62 20
Accounts Receivable		 90 105 103 106 121
Prepaid Expenses		 6.84 5.28 5.89 8.20 6.91
Current Deferred & Refundable Income Taxes		 6.20 8.37 9.13 10 8.97
Other Current Assets		 2.23 1.96 2.19 1.57 2.04
Plant, Property, & Equipment, net		 38 36 31 0.00 0.00
Total Noncurrent Assets		 90 93 87 118 113
Goodwill		 12 12 12 12 12
Noncurrent Deferred & Refundable Income Taxes		 4.34 4.29 4.00 4.41 5.05
Other Noncurrent Operating Assets		 74 77 71 101 97
Total Liabilities & Shareholders' Equity		 295 298 290 306 272
Total Liabilities		 139 142 130 135 164
Total Current Liabilities		 74 74 71 78 111
Short-Term Debt		 0.40 0.44 0.59 0.70 33
Accounts Payable		 18 18 18 20 20
Current Deferred Revenue		 5.92 6.46 5.40 4.87 7.22
Current Deferred & Payable Income Tax Liabilities		 3.16 3.35 3.32 5.89 4.64
Current Employee Benefit Liabilities		 33 32 31 34 33
Other Current Liabilities		 13 14 13 12 12
Total Noncurrent Liabilities		 66 68 60 57 53
Long-Term Debt		 0.58 0.56 0.82 0.80 0.70
Noncurrent Deferred Revenue		 1.50 1.63 1.30 1.08 1.12
Other Noncurrent Operating Liabilities		 64 66 57 56 51
Total Equity & Noncontrolling Interests		 156 156 159 171 109
Total Preferred & Common Equity		 156 156 159 171 109
Total Common Equity		 156 156 159 171 109
Common Stock		 206 208 209 211 212
Retained Earnings		 -37 -31 -21 -3.59 5.68
Treasury Stock		 -5.73 -14 -22 -30 -102
Accumulated Other Comprehensive Income / (Loss)		 -7.21 -6.13 -6.55 -6.15 -7.25

Annual Metrics and Ratios for IBEX

This table displays calculated financial ratios and metrics derived from IBEX's official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024
Growth Metrics		 - - - - - - -
Revenue Growth		 0.00% 7.65% 9.98% 9.44% 11.16% 6.14% -2.78%
EBITDA Growth		 0.00% 354.93% 63.67% -11.62% 24.27% 53.55% -0.96%
EBIT Growth		 0.00% 95.67% 1,215.60% 69.01% 21.00% 96.26% -2.59%
NOPAT Growth		 0.00% 136.23% 287.06% -15.63% 55.10% 38.82% 2.13%
Net Income Growth		 0.00% 169.04% -29.14% 68.46% 63.92% 47.19% 6.56%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 61.97% 45.22% 10.18%
Operating Cash Flow Growth		 0.00% 138.32% 2,248.73% -68.91% 148.84% 4.63% -14.24%
Free Cash Flow Firm Growth		 0.00% 0.00% 143.00% -145.47% 394.56% -70.75% 15.10%
Invested Capital Growth		 0.00% 0.00% -26.06% 42.80% -33.50% 16.40% 11.82%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.02%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.52%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 13.09%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.26%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.84%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 20.26%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -0.04%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -4.95%
Profitability Metrics		 - - - - - - -
Gross Margin		 23.64% 29.78% 31.72% 100.00% 100.00% 100.00% 100.00%
EBITDA Margin		 -2.47% 5.85% 8.70% 7.03% 7.86% 11.37% 11.58%
Operating Margin		 -5.19% 1.75% 5.59% 3.84% 4.18% 7.74% 7.75%
EBIT Margin		 -6.10% -0.25% 2.49% 3.84% 4.18% 7.74% 7.75%
Profit (Net Income) Margin		 -4.64% 2.98% 1.92% 2.95% 4.35% 6.04% 6.62%
Tax Burden Percent		 76.09% -1,212.94% 77.05% 86.38% 110.72% 78.32% 82.11%
Interest Burden Percent		 100.00% 100.00% 100.00% 88.90% 93.96% 99.62% 103.95%
Effective Tax Rate		 0.00% 0.00% 22.95% 13.62% -10.72% 21.68% 17.89%
Return on Invested Capital (ROIC)		 0.00% 7.88% 17.53% 14.33% 22.70% 36.46% 32.68%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 20.08% 6.42% 11.32% -16.10% 36.72% 30.50%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 246.29% 45.19% 12.71% -0.59% -12.48% -11.36%
Return on Equity (ROE)		 0.00% 254.17% 62.72% 27.04% 22.11% 23.98% 21.32%
Cash Return on Invested Capital (CROIC)		 0.00% -192.12% 47.49% -20.92% 62.94% 21.30% 21.52%
Operating Return on Assets (OROA)		 0.00% -0.48% 5.26% 7.26% 7.26% 13.78% 13.43%
Return on Assets (ROA)		 0.00% 5.82% 4.05% 5.58% 7.55% 10.75% 11.46%
Return on Common Equity (ROCE)		 0.00% 254.17% 62.72% 27.04% 22.11% 23.98% 21.32%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 127.09% 48.12% 16.23% 18.91% 21.06% 20.30%
Net Operating Profit after Tax (NOPAT)		 -12 4.51 17 15 23 32 32
NOPAT Margin		 -3.64% 1.22% 4.31% 3.32% 4.63% 6.06% 6.37%
Net Nonoperating Expense Percent (NNEP)		 0.00% -12.20% 11.11% 3.01% 38.80% -0.27% 2.17%
Cost of Revenue to Revenue		 76.36% 70.22% 68.28% 0.00% 0.00% 0.00% 0.00%
SG&A Expenses to Revenue		 0.00% 7.57% 4.28% 17.36% 16.26% 16.95% 18.31%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 28.83% 28.03% 26.13% 96.16% 95.82% 92.26% 92.25%
Earnings before Interest and Taxes (EBIT)		 -21 -0.90 10 17 21 40 39
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -8.45 22 35 31 39 59 59
Valuation Ratios		 - - - - - - -
Price to Book Value (P/BV)		 0.00 10.49 5.60 3.16 2.74 2.58 1.68
Price to Tangible Book Value (P/TBV)		 0.00 0.00 58.94 3.88 3.05 2.80 1.81
Price to Revenue (P/Rev)		 0.26 0.25 0.22 0.57 0.63 0.74 0.55
Price to Earnings (P/E)		 0.00 8.25 11.64 19.46 14.47 12.27 8.28
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 12.12% 8.59% 5.14% 6.91% 8.15% 12.08%
Enterprise Value to Invested Capital (EV/IC)		 0.00 1.65 1.91 2.46 3.45 3.54 2.08
Enterprise Value to Revenue (EV/Rev)		 0.00 0.51 0.40 0.67 0.56 0.63 0.43
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 8.77 4.58 9.53 7.16 5.57 3.69
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 16.02 17.42 13.44 8.18 5.51
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 41.92 9.26 20.17 12.14 10.44 6.71
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 85.83 3.12 18.47 6.93 7.91 6.05
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 3.42 0.00 4.38 17.87 10.19
Leverage & Solvency		 - - - - - - -
Debt to Equity		 0.00 12.47 5.78 1.24 0.14 0.01 0.01
Long-Term Debt to Equity		 0.00 7.62 4.08 0.91 0.01 0.00 0.01
Financial Leverage		 0.00 12.27 7.04 1.12 0.04 -0.34 -0.37
Leverage Ratio		 0.00 21.82 15.48 4.85 2.93 2.23 1.86
Compound Leverage Factor		 0.00 21.82 15.48 4.31 2.75 2.22 1.93
Debt to Total Capital		 0.00% 92.58% 85.25% 55.45% 12.18% 0.67% 0.91%
Short-Term Debt to Total Capital		 0.00% 35.99% 25.10% 14.76% 11.67% 0.27% 0.39%
Long-Term Debt to Total Capital		 0.00% 56.59% 60.14% 40.69% 0.51% 0.40% 0.52%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 7.42% 14.75% 44.55% 87.82% 99.33% 99.09%
Debt to EBITDA		 0.00 5.00 2.65 3.22 0.41 0.02 0.03
Net Debt to EBITDA		 0.00 4.57 2.02 1.36 -0.85 -0.95 -1.04
Long-Term Debt to EBITDA		 0.00 3.05 1.87 2.36 0.02 0.01 0.01
Debt to NOPAT		 0.00 23.87 5.35 6.82 0.69 0.03 0.05
Net Debt to NOPAT		 0.00 21.85 4.07 2.87 -1.45 -1.78 -1.89
Long-Term Debt to NOPAT		 0.00 14.59 3.77 5.00 0.03 0.02 0.03
Altman Z-Score		 0.00 1.18 1.64 2.20 2.76 4.00 3.87
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - -
Current Ratio		 0.00 0.73 0.81 1.34 1.46 2.17 2.53
Quick Ratio		 0.00 0.73 0.81 1.33 1.27 1.96 2.27
Cash Flow Metrics		 - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -110 47 -21 63 19 21
Operating Cash Flow to CapEx		 -110.65% 39.24% 1,207.54% 77.21% 154.35% 220.87% 405.42%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 -11.36 49.13 23.39 41.48
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 8.50 31.04 52.85 69.84
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 -2.51 10.93 28.92 52.62
Efficiency Ratios		 - - - - - - -
Asset Turnover		 0.00 1.96 2.11 1.89 1.73 1.78 1.73
Accounts Receivable Turnover		 0.00 5.05 5.91 6.03 6.23 6.46 5.50
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 4.48 4.85 7.68 13.55 0.00 0.00
Accounts Payable Turnover		 0.00 5.52 5.53 0.00 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 72.23 61.74 60.52 58.61 56.46 66.37
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 66.16 66.04 0.00 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 6.07 -4.30 60.52 58.61 56.46 66.37
Capital & Investment Metrics		 - - - - - - -
Invested Capital		 0.00 114 85 121 80 94 105
Invested Capital Turnover		 0.00 6.44 4.07 4.32 4.90 6.02 5.13
Increase / (Decrease) in Invested Capital		 0.00 114 -30 36 -40 13 11
Enterprise Value (EV)		 0.00 189 162 297 277 331 217
Market Capitalization		 90 90 90 255 310 387 279
Book Value per Share		 $0.00 $1.81 $1.24 $6.18 $6.17 $8.22 $9.63
Tangible Book Value per Share		 $0.00 ($1.29) $0.12 $5.03 $5.52 $7.57 $8.94
Total Capital		 0.00 116 109 181 129 151 167
Total Debt		 0.00 108 93 100 16 1.01 1.53
Total Long-Term Debt		 0.00 66 66 74 0.66 0.60 0.87
Net Debt		 0.00 99 71 42 -33 -56 -61
Capital Expenditures (CapEx)		 5.19 5.61 4.28 21 26 19 8.86
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 3.36 -14 4.53 11 28 47
Debt-free Net Working Capital (DFNWC)		 0.00 12 7.86 62 60 86 110
Net Working Capital (NWC)		 0.00 -30 -20 36 45 85 109
Net Nonoperating Expense (NNE)		 3.44 -6.46 9.68 1.63 1.38 0.12 -1.28
Net Nonoperating Obligations (NNO)		 0.00 106 68 40 -33 -56 -61
Total Depreciation and Amortization (D&A)		 12 22 25 14 18 19 19
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.91% -3.46% 1.02% 2.20% 5.42% 9.22%
Debt-free Net Working Capital to Revenue		 0.00% 3.32% 1.94% 14.07% 12.10% 16.39% 21.56%
Net Working Capital to Revenue		 0.00% -8.04% -4.84% 8.04% 9.04% 16.31% 21.43%
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.16 $0.00 $1.74 $1.90
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 13.05M 18.40M 18.25M 18.20M 17.70M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.15 $0.00 $1.67 $1.84
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 13.05M 18.40M 18.25M 18.89M 18.26M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 13.05M 18.40M 18.25M 18.30M 16.80M
Normalized Net Operating Profit after Tax (NOPAT)		 -12 4.51 17 15 14 32 32
Normalized NOPAT Margin		 -3.64% 1.22% 4.31% 3.32% 2.93% 6.06% 6.37%
Pre Tax Income Margin		 -6.10% -0.25% 2.49% 3.42% 3.93% 7.71% 8.06%
Debt Service Ratios		 - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 9.01 16.00 51.11 76.71
NOPAT to Interest Expense		 0.00 0.00 0.00 7.78 17.72 40.03 62.99
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 -2.00 -4.11 27.18 59.48
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 -3.22 -2.39 16.10 45.76
Payout Ratios		 - - - - - - -
Dividend Payout Ratio		 -0.92% 14.59% 1.56% 30.56% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -0.92% 14.59% 1.56% 38.77% 15.87% 0.87% 64.05%

Quarterly Metrics and Ratios for IBEX

This table displays calculated financial ratios and metrics derived from IBEX's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% -2.50% -4.80% -3.62% 0.08% 4.10% 6.07%
EBITDA Growth		 0.00% 0.00% 0.00% 0.00% 8.31% -25.82% -8.90% 30.84% 0.66% 36.33%
EBIT Growth		 0.00% 0.00% 0.00% 0.00% 8.62% -39.33% -13.55% 54.94% 9.13% 71.70%
NOPAT Growth		 0.00% 0.00% 0.00% 0.00% 6.20% -38.92% -10.33% 112.50% 2.55% 65.66%
Net Income Growth		 0.00% 0.00% 0.00% 0.00% 13.83% -34.47% -8.59% 118.29% 1.43% 52.56%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 11.43% -32.65% -3.39% 129.17% 10.26% 72.73%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% 56.13% -130.93% -15.76% -0.07% -10.62% 169.70%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 90.79% 95.09%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.82% 16.11% 13.46%
Revenue Q/Q Growth		 0.00% 9.01% -5.58% -5.42% 0.14% 6.44% -4.40% -1.79% 4.16% 8.45%
EBITDA Q/Q Growth		 0.00% 29.85% 10.55% -24.64% 0.11% -11.07% 35.77% 8.24% -22.98% 20.45%
EBIT Q/Q Growth		 0.00% 49.30% 13.97% -36.36% 0.30% -16.61% 62.40% 14.07% -29.35% 31.19%
NOPAT Q/Q Growth		 0.00% 42.27% 19.04% -59.76% 55.82% -18.17% 74.75% -4.63% -24.80% 32.19%
Net Income Q/Q Growth		 0.00% 42.11% 21.67% -60.01% 64.63% -18.18% 69.71% -4.51% -23.50% 23.06%
EPS Q/Q Growth		 0.00% 40.00% 20.41% -59.32% 62.50% -15.38% 72.73% -3.51% -21.82% 32.56%
Operating Cash Flow Q/Q Growth		 0.00% -4.84% 156.36% 28.49% -50.19% -118.85% 798.29% 52.41% -55.45% -85.30%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -16.35% 2.29% 98.51% -445.18% 37.90%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 1.54% 13.80% 1.81% -4.95% 5.43% 11.20%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 100.00% 100.00% 100.00% 100.00% 29.22% 27.71% 31.32% 246.92% 100.00% 100.00%
EBITDA Margin		 9.66% 11.51% 13.47% 10.74% 10.73% 8.97% 12.73% 14.03% 10.38% 11.53%
Operating Margin		 6.00% 8.22% 9.92% 6.68% 6.69% 5.24% 8.90% 10.33% 7.01% 8.48%
EBIT Margin		 6.00% 8.22% 9.92% 6.68% 6.69% 5.24% 8.90% 10.33% 7.01% 8.48%
Profit (Net Income) Margin		 5.10% 6.65% 8.57% 3.62% 5.96% 4.58% 8.13% 7.91% 5.81% 6.59%
Tax Burden Percent		 86.17% 82.12% 85.77% 54.23% 84.25% 82.68% 88.96% 74.38% 79.17% 79.77%
Interest Burden Percent		 98.70% 98.59% 100.77% 100.12% 105.79% 105.77% 102.72% 102.85% 104.63% 97.41%
Effective Tax Rate		 13.83% 17.88% 14.23% 45.77% 15.75% 17.32% 11.04% 25.62% 20.83% 20.23%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 20.24% 61.66% 41.12% 73.15% 39.46% 27.77% 30.58%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 20.23% 60.33% 39.74% 72.04% 38.99% 27.22% 32.02%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% -7.61% -23.61% -12.22% -22.27% -14.52% -10.14% -4.14%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 12.63% 38.06% 28.90% 50.87% 24.93% 17.63% 26.44%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 19.80% 0.00% 0.00% 0.00% 21.52% 16.81% 18.88%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 11.89% 11.76% 9.02% 15.62% 17.90% 11.97% 15.50%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 6.45% 10.48% 7.88% 14.28% 13.69% 9.91% 12.05%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 12.63% 38.06% 28.90% 50.87% 24.93% 17.63% 26.44%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 20.82% 18.76% 17.78% 0.00% 19.73% 33.92%
Net Operating Profit after Tax (NOPAT)		 6.61 9.40 11 4.50 7.02 5.74 10 9.57 7.20 9.51
NOPAT Margin		 5.17% 6.75% 8.51% 3.62% 5.63% 4.33% 7.92% 7.69% 5.55% 6.76%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 0.01% 1.33% 1.38% 1.11% 0.46% 0.55% -1.44%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - 3.66% - - - 6.66%
Cost of Revenue to Revenue		 0.00% 0.00% 0.00% 0.00% 70.78% 72.29% 68.68% -146.92% 0.00% 0.00%
SG&A Expenses to Revenue		 15.11% 16.87% 16.83% 19.06% 18.49% 18.74% 18.59% 17.41% 20.21% 18.27%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 94.00% 91.78% 90.08% 93.32% 22.54% 22.47% 22.42% 236.59% 92.99% 91.52%
Earnings before Interest and Taxes (EBIT)		 7.67 11 13 8.31 8.33 6.95 11 13 9.09 12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 12 16 18 13 13 12 16 17 13 16
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 2.58 1.81 2.18 1.70 1.68 1.96 3.31
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 2.80 1.96 2.36 1.84 1.81 2.11 3.71
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.74 0.54 0.66 0.53 0.55 0.65 0.69
Price to Earnings (P/E)		 0.00 0.00 0.00 12.27 8.71 11.64 9.57 8.28 9.94 9.75
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 8.15% 11.49% 8.59% 10.44% 12.08% 10.06% 10.26%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 3.54 2.33 2.71 2.02 2.08 2.49 3.05
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.63 0.43 0.57 0.44 0.43 0.54 0.72
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 5.57 3.67 5.20 4.05 3.69 4.66 5.91
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 8.18 5.39 8.00 6.36 5.51 6.84 8.28
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 10.44 6.90 10.27 8.10 6.71 8.45 10.30
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 7.91 4.93 7.70 6.18 6.05 7.86 9.91
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10.19 15.94 17.17
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.31
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.01
Financial Leverage		 0.00 0.00 0.00 -0.38 -0.39 -0.31 -0.31 -0.37 -0.37 -0.13
Leverage Ratio		 0.00 0.00 0.00 2.23 1.89 1.91 1.82 1.86 1.84 2.15
Compound Leverage Factor		 0.00 0.00 0.00 2.23 2.00 2.02 1.87 1.91 1.92 2.10
Debt to Total Capital		 0.00% 0.00% 0.00% 0.67% 0.62% 0.64% 0.87% 0.91% 0.87% 23.74%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.27% 0.25% 0.28% 0.36% 0.39% 0.40% 23.25%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.40% 0.37% 0.36% 0.51% 0.52% 0.46% 0.49%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% 99.33% 99.38% 99.36% 99.13% 99.09% 99.13% 76.26%
Debt to EBITDA		 0.00 0.00 0.00 0.02 0.02 0.02 0.03 0.03 0.03 0.54
Net Debt to EBITDA		 0.00 0.00 0.00 -0.95 -1.01 -0.85 -0.90 -1.04 -1.03 0.22
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.01 0.01 0.01
Debt to NOPAT		 0.00 0.00 0.00 0.03 0.03 0.04 0.05 0.05 0.05 0.93
Net Debt to NOPAT		 0.00 0.00 0.00 -1.78 -1.90 -1.68 -1.80 -1.89 -1.87 0.38
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.02 0.02 0.02 0.03 0.03 0.02 0.02
Altman Z-Score		 0.00 0.00 0.00 3.63 3.27 3.47 3.45 3.57 3.68 3.62
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 0.00 0.00 0.00 2.17 2.27 2.28 2.42 2.53 2.42 1.44
Quick Ratio		 0.00 0.00 0.00 1.96 2.07 2.07 2.18 2.27 2.17 1.28
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 0.00 -88 -102 -100 -1.49 -8.10 -5.03
Operating Cash Flow to CapEx		 156.32% 66.60% 364.27% 468.56% 423.20% -56.60% 675.99% 784.77% 213.83% 26.42%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 -845.85 -922.11 -806.57 -8.49 -50.01 -8.11
Operating Cash Flow to Interest Expense		 37.58 17.64 129.23 72.95 83.50 -14.75 92.19 99.55 47.91 1.84
Operating Cash Flow Less CapEx to Interest Expense		 13.54 -8.85 93.75 57.38 63.77 -40.80 78.55 86.87 25.51 -5.13
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 1.78 1.76 1.72 1.76 1.73 1.71 1.83
Accounts Receivable Turnover		 0.00 0.00 0.00 6.46 5.76 4.89 4.91 5.50 5.23 4.62
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 13.72 14.28 16.16 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 4.84 10.26 31.81 0.00 0.00 0.00
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 56.46 63.33 74.59 74.28 66.37 69.82 78.98
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 75.49 35.56 11.47 0.00 0.00 0.00
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 56.46 -12.16 39.03 62.81 66.37 69.82 78.98
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 0.00 0.00 0.00 94 95 108 110 105 110 123
Invested Capital Turnover		 0.00 0.00 0.00 5.59 10.95 9.50 9.24 5.13 5.00 4.52
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 0.00 95 108 110 11 15 15
Enterprise Value (EV)		 0.00 0.00 0.00 331 222 293 222 217 275 374
Market Capitalization		 342 453 445 387 283 341 271 279 336 360
Book Value per Share		 $0.00 $0.00 $0.00 $8.22 $8.52 $8.70 $9.07 $9.63 $10.18 $6.50
Tangible Book Value per Share		 $0.00 $0.00 $0.00 $7.57 $7.88 $8.04 $8.39 $8.94 $9.48 $5.79
Total Capital		 0.00 0.00 0.00 151 157 157 161 167 173 143
Total Debt		 0.00 0.00 0.00 1.01 0.98 1.00 1.41 1.53 1.50 34
Total Long-Term Debt		 0.00 0.00 0.00 0.60 0.58 0.56 0.82 0.87 0.80 0.70
Net Debt		 0.00 0.00 0.00 -56 -61 -48 -49 -61 -61 14
Capital Expenditures (CapEx)		 3.56 7.95 3.73 3.72 2.05 2.89 1.69 2.22 3.63 4.32
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 28 32 47 51 47 49 61
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 86 94 96 101 110 111 82
Net Working Capital (NWC)		 0.00 0.00 0.00 85 94 95 101 109 111 48
Net Nonoperating Expense (NNE)		 0.09 0.13 -0.09 -0.01 -0.41 -0.33 -0.27 -0.27 -0.33 0.25
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 -56 -61 -48 -49 -61 -61 14
Total Depreciation and Amortization (D&A)		 4.68 4.58 4.67 5.05 5.04 4.95 4.87 4.61 4.37 4.29
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 5.42% 6.18% 9.10% 9.93% 9.22% 9.57% 11.77%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 16.39% 18.12% 18.65% 19.90% 21.56% 21.70% 15.64%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 16.31% 18.04% 18.56% 19.78% 21.43% 21.56% 9.27%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.25 $0.41 $0.34 $0.59 $0.56 $0.45 $0.61
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 18.20M 18.29M 17.89M 17.47M 17.70M 16.88M 15.13M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.24 $0.39 $0.33 $0.57 $0.55 $0.43 $0.57
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 18.89M 18.90M 18.44M 18.04M 18.26M 17.49M 16.46M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 18.30M 17.94M 17.57M 17.21M 16.80M 16.76M 13.19M
Normalized Net Operating Profit after Tax (NOPAT)		 6.61 9.40 11 4.50 7.02 5.74 10 9.57 7.20 9.51
Normalized NOPAT Margin		 5.17% 6.75% 8.51% 3.62% 5.63% 4.33% 7.92% 7.69% 5.55% 6.76%
Pre Tax Income Margin		 5.92% 8.10% 10.00% 6.68% 7.07% 5.54% 9.14% 10.63% 7.33% 8.26%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 51.82 38.17 124.30 34.75 80.11 62.59 90.98 73.54 56.12 19.24
NOPAT to Interest Expense		 44.66 31.34 106.60 18.85 67.49 51.74 80.94 54.70 44.43 15.35
EBIT Less CapEx to Interest Expense		 27.78 11.68 88.82 19.18 60.38 36.53 77.35 60.85 33.72 12.27
NOPAT Less CapEx to Interest Expense		 20.62 4.85 71.13 3.28 47.76 25.69 67.31 42.01 22.02 8.38
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.87% 5.64% 35.08% 65.50% 64.05% 72.66% 169.54%

Frequently Asked Questions About IBEX's Financials

When does IBEX's fiscal year end?

According to the most recent income statement we have on file, IBEX's financial year ends in June. Their financial year 2024 ended on June 30, 2024.

How has IBEX's net income changed over the last 6 years?

IBEX's net income appears to be on an upward trend, with a most recent value of $33.66 million in 2024, falling from -$15.88 million in 2018. The previous period was $31.58 million in 2023.

What is IBEX's operating income?
IBEX's total operating income in 2024 was $39.43 million, based on the following breakdown:
  • Total Gross Profit: $508.57 million
  • Total Operating Expenses: $469.14 million
How has IBEX revenue changed over the last 6 years?

Over the last 6 years, IBEX's total revenue changed from $342.20 million in 2018 to $508.57 million in 2024, a change of 48.6%.

How much debt does IBEX have?

IBEX's total liabilities were at $128.11 million at the end of 2024, a 10.6% decrease from 2023, and a 28.7% decrease since 2019.

How much cash does IBEX have?

In the past 5 years, IBEX's cash and equivalents has ranged from $8.87 million in 2019 to $62.72 million in 2024, and is currently $62.72 million as of their latest financial filing in 2024.

How has IBEX's book value per share changed over the last 6 years?

Over the last 6 years, IBEX's book value per share changed from 0.00 in 2018 to 9.63 in 2024, a change of 963.1%.


Related Companies

This page (NASDAQ:IBEX) was last updated on 4/20/2025 by MarketBeat.com Staff
From Our Partners
The real reason gold is soaring (and likely to continue)
Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...
Golden Portfolio | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
The first casualty of the 2025 trade war
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
Read before the next tariff announcement
Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...
Brownstone Research | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored